Mme Docteur DJAMILA ZERKAK

Localisation

Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.

Lieux de consultation

• CABINET DU DR DJAMILA ZERKAK

  12 RUE DE LA CHAUSSEE D ANTIN, 75009 Paris

  Libéral
  23 m25 m26 m26 m

  © OpenStreetMap · Photos Wikimedia Commons (CC)

  📷 Street View ↗🗺️ Maps ↗OSM ↗

• GHU APHP SUN SITE PITIE SALPETRIERE

  47-83 — 47 Boulevard DE L HOPITAL, 75651 Paris 13e Arrondissement

  ☎ 0142160000Hospitalier🏥 Voir cet établissement

Tarifs & secteur de conventionnement

Prendre rendez-vous & contact

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Top publications · les plus citées

• 1

  Unité Rhumatologique des Affections de la Main (URAM) scale: development and validation of a tool to assess Dupuytren's disease-specific disability

  Arthritis care & research · 2011

  📚 89 citations🎯 RCR 5.24Top 7% NIH

  Lire l'abstract Crossref ↓

  AbstractObjectiveTo our knowledge, no functional outcome measure has been developed and validated for Dupuytren's disease. We aimed to develop and validate a patient‐reported functional outcome measure for Dupuytren's disease.MethodsPatients with Dupuytren's disease (n = 9) and medical experts (n = 7) provided input and opinions about limiting activities that were difficult to perform because of Dupuytren's disease for item generation. The provisional scale was studied in an independent sample of patients (n = 85) for item reduction according to response distribution, reliability, redundancy, and loading in a 1‐factor solution. The final scale was evaluated as follows: reliability using Cronbach's alpha coefficient and test–retest intraclass correlation coefficient from the previous 85‐patient population, and construct validity and responsiveness after needle aponeurotomy in another independent 53‐patient sample. For construct validity, convergent validity and divergent validity were tested. The clinically important change was estimated relative to a 1‐point categorical change on the Tubiana scale.ResultsA 52‐item provisional scale was generated and reduced to the final 9‐item scale called the Unité Rhumatologique des Affections de la Main (URAM) scale (total score 0–45). The scale showed good to excellent reliability and suitable construct validity. The URAM score improved after needle aponeurotomy: the standardized effect size was 0.56. The estimated clinically important change of the URAM scale was 2.9 points.ConclusionWe provide the first patient‐reported functional measure for Dupuytren's disease. The URAM scale demonstrated suitable psychometric properties, and is short and convenient enough for easy use in daily practice and in clinical studies.

• 2

  Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice?

  The Journal of rheumatology · 2006

  📚 42 citations🎯 RCR 1.34
• 3

  Effect of a collective educational program for patients with rheumatoid arthritis: a prospective 12-month randomized controlled trial

  The Journal of rheumatology · 2007

  📚 41 citations🎯 RCR 1.58🩺 Clinique

Publications scientifiques (13) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Partager cette fiche